
Elsin Pharmaceuticals Private Limited
Founded in 2017 and headquartered in Uttarakhand, India.
Founded in 2017 and headquartered in Uttarakhand, India.
Udham Singh Nagar, Uttarakhand, India
+91-XXXXXXXXXX
U51909UR2017PTC008318
008318
Private Limited Indian Non-Government Company
13 Dec 2017
15 Jul 2020
31 Mar 2020
Unlisted
Roc Uttarakhand
Name | Designation | Appointment Date | Status |
---|---|---|---|
Santosh Rawat ![]() | Director | 13-Dec-2017 | Current |
Shailendra Rawat ![]() | Director | 13-Dec-2017 | Current |
Enhance accessibility to Elsin Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Elsin Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Elsin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Elsin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elsin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Elsin Pharmaceuticals Private Limited last Annual general meeting of members was held on 15 Jul 2020 as per latest MCA records.
Elsin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Uttarakhand.
Santosh Rawat was appointed as a Director was appointed as a Director on 13 Dec 2017 & has been associated with this company since 7 years 4 months .
Shailendra Singh Rawat was appointed as a Director was appointed as a Director on 13 Dec 2017 & has been associated with this company since 7 years 4 months .
Elsin Pharmaceuticals Private Limited was registered on 13 Dec 2017 with Roc Uttarakhand & aged 7 years 4 months as per MCA records.
Elsin Pharmaceuticals Private Limited was incorporated on 13 Dec 2017.
The authorized share capital of Elsin Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Elsin Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Elsin Pharmaceuticals Private Limited is 7 Achnal Gali, Stadium Road R.K Puram India, Kashipur, Uttarakhand, 244713.
The corporate identification number (CIN) of Elsin Pharmaceuticals Private Limited is U51909UR2017PTC008318 and the company number is 008318 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Elsin Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2020.
Search company & director profiles for free and gain access to critical business data.